BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

55 related articles for article (PubMed ID: 7500435)

  • 1. Endometrial thickness in tamoxifen-treated women.
    Li YT; Chang WH; Wang PH
    Taiwan J Obstet Gynecol; 2023 Nov; 62(6):799-801. PubMed ID: 38008496
    [No Abstract]   [Full Text] [Related]  

  • 2. Dienogest suppresses cellular proliferation status of endometrial polyps and acts differently depending on the morphological type.
    Inaba K; Wada-Hiraike O; Harada M; Hirota Y; Koga K; Fujii T; Osuga Y
    Womens Health (Lond); 2020; 16():1745506520952003. PubMed ID: 32833600
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Tamoxifen-associated Endometrial Cancer after Treatment in Young Premenopausal Women with Breast Cancer: A Case Report.
    Hermansyah D; Al Anas M; Yaznil MR; Lubis AT; Alianto R
    Acta Inform Med; 2023; 32(1):85-87. PubMed ID: 38585594
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Measuring uterine cavity volume with sonohysterography: A new objective method.
    Elsayed M; Amer MI; Gamal R; Haggag A; Mashaly AR; Absi TE; Elsayed W
    Ultrasound; 2024 May; 32(2):94-101. PubMed ID: 38694830
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ultrasonography for menopausal endometrium.
    Li YT; Yang ST; Wang PH
    Taiwan J Obstet Gynecol; 2023 Nov; 62(6):797-798. PubMed ID: 38008495
    [No Abstract]   [Full Text] [Related]  

  • 6. The effect of tamoxifen on the genital tract.
    Polin SA; Ascher SM
    Cancer Imaging; 2008 Jun; 8(1):135-45. PubMed ID: 18603495
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cancer of the endometrium: current aspects of diagnostics and treatment.
    Münstedt K; Grant P; Woenckhaus J; Roth G; Tinneberg HR
    World J Surg Oncol; 2004 Jul; 2():24. PubMed ID: 15268760
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Section 8--clinical relevance. American Institute of Ultrasound in Medicine.
    J Ultrasound Med; 2000 Feb; 19(2):149-68. PubMed ID: 10680620
    [No Abstract]   [Full Text] [Related]  

  • 9. Section 7--discussion of the mechanical index and other exposure parameters. American Institute of Ultrasound in Medicine.
    J Ultrasound Med; 2000 Feb; 19(2):143-8, 154-68. PubMed ID: 10680619
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Section 6--mechanical bioeffects in the presence of gas-carrier ultrasound contrast agents. American Institute of Ultrasound in Medicine.
    J Ultrasound Med; 2000 Feb; 19(2):120-42, 154-68. PubMed ID: 10680618
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Section 4--bioeffects in tissues with gas bodies. American Institute of Ultrasound in Medicine.
    J Ultrasound Med; 2000 Feb; 19(2):97-108, 154-68. PubMed ID: 10680616
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tamoxifen and secondary tumours. An update.
    Wilking N; Isaksson E; von Schoultz E
    Drug Saf; 1997 Feb; 16(2):104-17. PubMed ID: 9067122
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Abnormalities detected on transvaginal ultrasonography in tamoxifen-treated postmenopausal breast cancer patients may represent endometrial cystic atrophy.
    McGonigle KF; Shaw SL; Vasilev SA; Odom-Maryon T; Roy S; Simpson JF
    Am J Obstet Gynecol; 1998 Jun; 178(6):1145-50. PubMed ID: 9662294
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Sonohysterography for evaluation of the endometrium in women treated with tamoxifen.
    Hann LE; Gretz EM; Bach AM; Francis SM
    AJR Am J Roentgenol; 2001 Aug; 177(2):337-42. PubMed ID: 11461858
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hysteroscopically targeted biopsies compared with blind samplings in endometrial assessment of menopausal women taking tamoxifen for breast cancer.
    Garuti G; Cellani F; Colonnelli M; Garzia D; Gonfiantini C; Luerti M
    J Am Assoc Gynecol Laparosc; 2004 Feb; 11(1):62-7. PubMed ID: 15104834
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Risk Factors Associated with Endometrial Pathology in Premenopausal Breast Cancer Patients Treated with Tamoxifen.
    Lee M; Piao J; Jeon MJ
    Yonsei Med J; 2020 Apr; 61(4):317-322. PubMed ID: 32233174
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Benign endometrial lesions induced by tamoxifen].
    De Muylder X
    J Gynecol Obstet Biol Reprod (Paris); 1999 Sep; 28(5):420-4. PubMed ID: 10566160
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Sonohysterography for ultrasonographic evaluation of tamoxifen-associated cystic thickened endometrium.
    Achiron R; Lipitz S; Sivan E; Goldenberg M; Mashiach S
    J Ultrasound Med; 1995 Sep; 14(9):685-8. PubMed ID: 7500435
    [TBL] [Abstract][Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 3.